The molecular landscape of oligodendrogliomas includes frequent TERTp mutations (55), retained ATRX expression, and the absence of p53 accumulation, as 1p/19q codeletion is mutually exclusive with TP53 and ATRX alterations (56, 57). This evidence concerns the gene TP53 and oligodendroglioma.